Peer review process
Revised: This Reviewed Preprint has been revised by the authors in response to the previous round of peer review; the eLife assessment and the public reviews have been updated where necessary by the editors and peer reviewers.
Read more about eLife’s peer review process.Editors
- Reviewing EditorVolker DötschGoethe University Frankfurt, Frankfurt am Main, Germany
- Senior EditorVolker DötschGoethe University Frankfurt, Frankfurt am Main, Germany
Reviewer #1 (Public review):
Summary and Strengths:
The very well-written manuscript by Lövestam et al. from the Scheres/Goedert groups entitled "Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments" demonstrates the in vitro production of the so-called paired helical filament Alzheimer's disease (AD) polymorph fold of tau amyloids through the introduction of 12 point mutations that attempt to mimic the disease-associated hyper-phosphorylation of tau. The presented work is very important because it enables disease-related scientific work, including seeded amyloid replication in cells, to be performed in vitro using recombinant-expressed tau protein.
Comments on revised version:
The manuscript is significantly improved, as also indicated by Reviewer 2, with the 100% formation of the PHF and the additional experiments to elucidate on the potential mechanism by the PTMs. This is a great work.
Reviewer #2 (Public review):
Summary:
This manuscript addresses an important impediment in the field of Alzheimer's disease (AD) and tauapathy research by showing that 12 specific phosphomimetic mutations in full-length tau allow the protein to aggregate into fibrils with the AD fold and the fold of chronic traumatic encephalopathy fibrils in vitro. The paper presents comprehensive structural and cell based seeding data indicating the improvement of their approach over previous in vitro attempts on non-full-length tau constructs. The main weaknesses of this work results from the fact that only up to 70% of the tau fibrils form the desired fibril polymorphs. In addition, some of the figures are of low quality and confusing.
Strengths:
This study provides significant progress towards a very important and timely topic in the amyloid community, namely the in vitro production of tau fibrils found in patients.
The 12 specific phosphomimetic mutations presented in this work will have an immediate impact in the field since they can be easily reproduced.
Multiple high-resolution structures support the success of the phosphomimetic mutation approach.
Additional data show the seeding efficiency of the resulting fibrils, their reduced tendency to bundle, and their ability to be labeled without affecting core structure or seeding capability.
Comments on revised version:
Generally, I am satisfied with the revisions. Specifically, the new results showing 100% formation of PHF is a significant improvement.